排石效灵方联合坦索罗辛治疗输尿管结石术后结石残留的临床研究

Clinical Study of the Combination of Paishi Xiaoling Fang and Tamsulosin in the Treatment of Ureteral Stones

目的 观察排石效灵方联合坦索罗辛治疗输尿管结石术后结石残留的疗效及不良反应。方法 选择2023年1月至2023年12月南京医科大学常州医学中心常州市妇幼保健院输尿管结石患者115例,按照就诊单双号法分为治疗组(n=58)和对照组(n=57)。治疗组予排石效灵方联合坦索罗辛治疗,对照组予坦索罗辛治疗。比较2组临床疗效、排石时间及不良反应。结果 治疗组总有效率84.48%,高于对照组的68.42%(P <0.05)。治疗组排石时间显著短于对照组(P <0.05)。2组不良反应比较差异无统计学意义(P> 0.05)。结论 排石效灵方联合坦索罗辛治疗输尿管结石的疗效良好,排石时间短,值得临床借鉴。

Objective To evaluate the therapeutic effect and side effects of Paishi Xiaoling Fang combined with Tamsulosin in the treatment of ureteral stones.Methods A total of 115 patients with ureteral stones were admitted to our hospital from January 2023 to December 2023 and divided into two groups based on their single or double hospital ID numbers.The treatment group(n=58)received Paishi Xiaoling Fang combined with Tamsulosin,while the control group(n=57)was treated with Tamsulosin alone.Clinical efficacy,stone excretion time,and adverse reactions were compared.Results The total effective rate in the treatment group was 84.48%,which was significantly higher than the control group's 68.42%(P<0.05).The stone excretion time in the treatment group was significantly shorter than in the control group(P<0.05),and no significant differences in adverse reactions were observed between the two groups(P>0.05).Conclusion Paishi Xiaoling Fang combined with Tamsulosin demonstrated good therapeutic efficacy and shorter stone excretion time in treating ureteral stones,making it a valuable clinical reference.